Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
Clinical trial NCT00431444 · COMPLETED
Trial details
- NCT number
- NCT00431444
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-07-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.